Emmessar Biotech opened at ₹25.46, in line with its previous close of ₹25.46. In the last trading session on 12 Nov 2026, the stock traded between ₹24.02 and ₹28.35, with an average traded price of ₹26.46. It showed an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Emmessar Biotech is now worth
₹ 10,054.00
Giving a profit of
₹ 54.00 (0.54%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+2.69 (+10.57%)
Day High
₹28.35
Day Low
₹24.02
Day Open
₹25.46
Prev Close
₹25.46
Volume
2,822
Value Traded
₹0.01 Cr
1W Return
23.79%
1M Return
24.61%
3M Return
15.13%
6M Return
7.24%
1Y Return
-9.19%
Market Cap (₹ Cr.)
14
PE Ratio
30.30
PB Ratio
1.52
Dividend Yield
-
ROE
5.37%
ROCE
6.36%
Book Value (₹)
16.78
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
23.79%
6 Weeks
-
1 Month
24.61%
3 Months
15.13%
9 Months
1.26%
No data available.
Emmessar Biotech Q2FY27 Results: Net profit up 23% YoY to ₹14.03 lakh
Net profit rose 23% YoY to ₹14.03 lakh in Q2FY27. Revenue from operations increased 19% YoY to ₹10.92 lakh. Other expenditure dropped significantly to ₹6.59 lakh from ₹19.90 lakh. Total assets grew to ₹989.25 lakh as of September 30, 2026.
10 days agoEmmessar Biotech 34th AGM passes all resolutions with 95.31% votes in favour
All four resolutions at Emmessar Biotech & Nutrition Limited's 34th AGM held on September 29, 2026 were passed with requisite majority. Total votes polled stood at 1,673,896, representing 33.50% of outstanding shares of 4,996,100. 95.31% of votes polled were cast in favour across all resolutions; 4.69% were against. Promoter and Promoter Group voted 100% in favour; public non-institutional voters cast 74.98% of their polled votes against. Special resolutions re-appointing Srinivasa Raghavan Mathurakavi Ayyangar as Managing Director and Jeyavel Balaiah Nadar as Whole Time Director, each for a further 5 years, were both passed.
1mo agoEmmessar Biotech to hold AGM on Sept 29; reappoints MD, WTD
Emmessar Biotech schedules its 34th AGM for September 29, 2026. Shareholders to reappoint MD Srinivasa Raghavan Mathurakavi Ayyangar for five years. WTD Jeyavel Balaiah Nadar seeks reappointment until February 2031. Remote e-voting opens on September 26 with a cutoff date of September 22.
2mo agoEmmessar Biotech sets 34th AGM for September 29 via video conferencing
Emmessar Biotech schedules its 34th AGM for September 29, 2026. The meeting will be held via video conferencing starting at 10:30 am. Notices and annual reports for FY26 are sent electronically only. Shareholders must register email IDs with RTA or DP to access documents.
2mo agoEmmessar Biotech & Nutrition net profit rises 23% in Q1FY27
Emmessar Biotech & Nutrition Ltd reported a 23% YoY rise in Q1FY27 net profit to ₹13.15 lakh, driven by stable rental income from leasehold land and effective cost management. Total income reached ₹59.85 lakh.
3mo agoEmmessar Biotech FY26 Net Profit Rises to ₹43.59 Lacs
Emmessar Biotech & Nutrition Limited published its audited financial results for FY26, reporting a net profit of ₹43.59 lacs, an increase from ₹31.62 lacs in FY25. Total income stood at ₹240.66 lacs, with revenue from operations declining to ₹37.08 lacs, while other income rose to ₹203.58 lacs. The company's total assets increased to ₹953.01 lacs, and shareholders' funds grew to ₹811.48 lacs.
6mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹19,420.00 | +0.75% | ₹1,75,731.69 | 74.40 | +37.89% | |
| ₹1,550.50 | -1.85% | ₹1,57,822.25 | 59.10 | +4.62% | |
| ₹2,472.50 | -0.18% | ₹73,291.04 | 32.30 | -15.94% | |
| ₹6,823.00 | +0.27% | ₹58,189.43 | 117.40 | +17.62% | |
| ₹4,776.10 | -0.79% | ₹52,465.46 | 79.80 | +29.10% | |
| ₹10,060.50 | +0.92% | ₹51,602.69 | 56.20 | +67.05% | |
| ₹557.30 | -0.93% | ₹28,119.92 | 33.00 | +21.20% | |
| ₹1,671.20 | -1.08% | ₹22,181.48 | 89.90 | +124.73% | |
| ₹1,602.80 | -1.38% | ₹21,861.08 | 20.90 | -7.14% | |
| ₹484.35 | +0.09% | ₹17,562.26 | 29.60 | +21.97% | |
| ₹5,339.00 | +0.12% | ₹16,369.36 | 34.00 | +25.06% | |
| ₹1,246.30 | -0.93% | ₹15,733.02 | 16.10 | -10.54% |
An investment of ₹10,000 made 5 years ago in Emmessar Biotech is now worth
₹ 10,054.00
Giving a profit of
₹ 54.00 (0.54%)
Note: Past profits do not guarantee future returns.
